Abstract
The application of intravenous gadolinium-based contrast agents (GBCA) is a great relief in the diagnosis and characterization of pathologic processes and course control, especially in multiple sclerosis (MS), where they play a large role in the detection of disease activity.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have